Back to Search Start Over

The value of disease prevention vs treatment

Authors :
Christoph M. Rheinberger
Daniel Herrera-Araujo
James K. Hammitt
European Chemicals Agency
Paris Jourdan Sciences Economiques (PJSE)
Université Panthéon-Sorbonne (UP1)-École normale supérieure - Paris (ENS Paris)-Institut National de la Recherche Agronomique (INRA)-École des hautes études en sciences sociales (EHESS)-École des Ponts ParisTech (ENPC)-Centre National de la Recherche Scientifique (CNRS)
Paris School of Economics (PSE)
Harvard University [Cambridge]
Toulouse School of Economics (TSE)
École des hautes études en sciences sociales (EHESS)-Institut National de la Recherche Agronomique (INRA)-Centre National de la Recherche Scientifique (CNRS)-Université Toulouse 1 Capitole (UT1)
European Chemicals Agency (ECHA)
Université Paris 1 Panthéon-Sorbonne (UP1)-École normale supérieure - Paris (ENS Paris)
Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-École des hautes études en sciences sociales (EHESS)-École des Ponts ParisTech (ENPC)-Centre National de la Recherche Scientifique (CNRS)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)
École des Ponts ParisTech (ENPC)-École normale supérieure - Paris (ENS Paris)
Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris 1 Panthéon-Sorbonne (UP1)-Centre National de la Recherche Scientifique (CNRS)-École des hautes études en sciences sociales (EHESS)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)
Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées
Université Toulouse 1 Capitole (UT1)
Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Recherche Agronomique (INRA)-École des hautes études en sciences sociales (EHESS)-Centre National de la Recherche Scientifique (CNRS)
Source :
Journal of Health Economics, Journal of Health Economics, Elsevier, 2016, 50, pp.247-255. ⟨10.1016/j.jhealeco.2016.08.005⟩
Publication Year :
2016
Publisher :
HAL CCSD, 2016.

Abstract

International audience; We present an integrated valuation model for diseases that are life-threatening. The model extends the standard one-period value-per-statistical-life model to three health prospects: healthy, ill, and dead. We derive willingness-to-pay values for prevention efforts that reduce a disease's incidence rate as well as for treatments that lower the corresponding health deterioration and mortality rates. We find that the demand value of prevention always exceeds that of treatment. People often overweight small risks and underweight large ones. We use the rank dependent utility framework to explore how the demand for prevention and treatment alters when people evaluate probabilities in a non-linear manner. For incidence and mortality rates associated with common types of cancers, the inverseS shaped probability weighting found in experimental studies leads to a significant increase in the demand values of both treatment and prevention.

Details

Language :
English
ISSN :
01676296
Database :
OpenAIRE
Journal :
Journal of Health Economics, Journal of Health Economics, Elsevier, 2016, 50, pp.247-255. ⟨10.1016/j.jhealeco.2016.08.005⟩
Accession number :
edsair.doi.dedup.....821013354d5c302c33e29de1c8fc41ca